Pnd74 - Cost Utility Model of Brivaracetam in the Adjunctive Treatment for Partial-Onset Epileptic Seizures in Spain

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2040
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Brivaracetam as Adjunctive Therapy for the Treatment of Partial-Onset Seizures in Patients With Epilepsy: The Current Evidence Base

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2016English

Health Technology Assessment of Lacosamide as Adjunctive Therapy for Partial-Onset Epileptic Seizures

2011English

Lamotrigine Extended-Release as Adjunctive Therapy for Partial Seizures

Neurology
Neurology
2009English

Cost of Illness of Partial Onset Seizures Epilepsy in Italy: Results From the Prometeo Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Role of Eslicarbazepine in the Treatment of Epilepsy in Adult Patients With Partial-Onset Seizures

Therapeutics and Clinical Risk Management
2010English

Inhomogeneous Cortical Synchronization and Partial Epileptic Seizures

Frontiers in Neurology
Neurology
2014English

A Cost-Effectiveness Model for Adjunctive Smoked Cannabis in the Treatment of Chronic Neuropathic Pain

Cannabis and Cannabinoid Research
Alternative MedicinePharmacologyComplementary
2019English

PND34 Cost-Utility Analysis of Lacosamide Adjunctive Therapy in the Treatment of Patients With Refractory in the Slovak Republic

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

The Frequency, Characteristics and Prognosis of Epileptic Seizures at the Onset of Stroke.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1988English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy